First Tracks Biotherapeutics (TRAX) AI Analysis
TRAX$46.56-0.54 -1.15%
Market cap$1.96BEnterprise value$1.46BRevenue (TTM)$0Market position—
Score
61
Neutral
Value
34
Quality
52
Growth
98
First Tracks Biotherapeutics is a growth-led story right now — Growth 98/100 is the pillar doing the heavy lifting (overall 61/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~53% upside.